Natera wins $19.3M patent infringement verdict against ArcherDX

A federal jury in Delaware awarded Natera a $19.3 million verdict in a patent infringement lawsuit against ArcherDX, a subsidiary of Invitae, finding ArcherDX's blood-based DNA testing technology for cancer detection violated three of Natera's patents. The award is about half the $38 million Natera sought.

Detected & updated continuously · Source: Nebula